Acta Pharmaceuticals

Seed
actapharmaceuticals.com Biotech & Healthcare Boston, United States
Total Funding $24M
Latest Round $24M Seed
Last Announced Oct 15, 2026
Investors 3 Backers
Decision Makers 1 Verified

About Acta Pharmaceuticals

Acta Pharmaceuticals focused on developing new therapies for early intervention and prevention of Alzheimer's disease.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Boston, United States
Tracked Since Oct 16, 2026

Web & Domain Identity

Official Website actapharmaceuticals.com
Domain Registered Date Nov 4, 2022

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $24,000,000 · Seed

    Backed by Alzheimer's Research Foundation, Dolby Family Ventures

  2. Milestone

    Website domain registered

    actapharmaceuticals.com

Investors & Backers

3
Alzheimer's Research Foundation
Dolby Family Ventures
Gamma Biosciences

Funding History

1 Round
Seed equity · Oct 15, 2026

Round backers: Alzheimer's Research Foundation, Dolby Family Ventures, Gamma Biosciences

$24,000,000 citybiz.co

Founders & Leadership

1

Rudolph E. Tanzi

Scientific Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts